Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05678556 · ClinicalTrials.gov registry record · NA
Effectiveness of Relationship Education for Reducing HIV Incidence Among SGM
A NA study of HIV and Gonorrhea, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 5,000
- Enrollment target
- 1
- Study location
NCT05678556 is a NA study of HIV and Gonorrhea that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 5,000 participants, above the 423-participant average among 303 other HIV trials with a reported enrollment target (1082% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05678556, a NA study of HIV and Gonorrhea, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to upgrade an existing relationship education and HIV prevention program. This program is designed for gay, bisexual, queer, and transgender and non-binary people who partner with cisgender men. This means the program is designed for gay, bisexual and queer men, including both cisgender and transgender men. It is also designed for transgender and non-binary people who partner with cisgender men, including both transfeminine and transmasculine people. The investigators aim to test the effectiveness of this updated program among couples and single people. Participants will complete online surveys and get tested for Chlamydia and Gonorrhea. Participants will be tested for urethral and rectal Chlamydia and Gonorrhea. Participants will also complete at-home point-of-care HIV testing, with confirmatory testing for preliminary positive results. They will also participate in our program on relationship education and HIV prevention. Study staff will follow up with participants for up to 2 years. All participants will be randomized into one of two different conditions: the all2GETHER program or no program. "Randomized" means that it is completely up to chance which condition participants will be put into. Participants have a 50% chance of being assigned to either condition, similar to a coin toss. Participants should expect that they will be in this research study for 2 years. Participation in this study will be done remotely - participants will never need to come into a research lab.
Interventions
- BEHAVIORAL all2GETHER
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2022-12-15 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05678556
The ClinicalTrials.gov registry entry for NCT05678556 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 423-participant average among 303 other HIV trials with a reported enrollment target (1082% higher). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which all2GETHER is the first listed.
NCT05678556 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05678556 about?
NCT05678556 is a clinical study titled "Effectiveness of Relationship Education for Reducing HIV Incidence Among SGM". The purpose of this study is to upgrade an existing relationship education and HIV prevention program. This program is designed for gay, bisexual, queer, and transgender and non-binary people who partner with cisgender men. This means the program is designed for gay, bisexual and queer men, includin...
What is the current status of trial NCT05678556?
This trial is currently recruiting. It is a NA study. The enrollment target is 5,000 participants. The study started on 2022-12-15. Estimated completion is 2026-03-31.
What conditions does trial NCT05678556 study?
This clinical trial studies the following conditions: HIV, Gonorrhea, Chlamydia.
What interventions are being tested in trial NCT05678556?
The interventions under investigation include: all2GETHER (BEHAVIORAL).
Who is sponsoring clinical trial NCT05678556?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05678556 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.